Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 1.0B
Gross Profit 288.6M 28.64%
Operating Income 155.4M 15.42%
Net Income 131.7M 13.07%
EPS (Diluted) $0.09

Balance Sheet Metrics

Total Assets 10.2B
Total Liabilities 3.0B
Shareholders Equity 7.2B
Debt to Equity 0.42

Cash Flow Metrics

Operating Cash Flow -197.3M
Free Cash Flow -1.2B

Revenue & Profitability Trend

Arcadium Lithium plc Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue1.0B882.5M813.2M420.4M288.2M
Cost of Goods Sold719.2M413.2M417.5M332.0M251.4M
Gross Profit288.6M469.3M395.7M88.4M36.8M
Operating Expenses133.2M69.0M60.3M52.6M48.4M
Operating Income155.4M400.3M336.6M35.5M-11.5M
Pre-tax Income210.6M389.0M335.4M23.9M-22.0M
Income Tax78.9M58.9M61.9M23.3M-5.7M
Net Income131.7M330.1M273.5M600.0K-16.3M
EPS (Diluted)$0.09$0.66$0.57$0.00-$0.05

Income Statement Trend

Arcadium Lithium plc Balance Sheet From 2021 to 2024

Metric20242023202220222021
Assets
Current Assets859.8M648.2M544.0M831.9M399.3M
Non-Current Assets9.3B2.6B1.5B3.7B803.2M
Total Assets10.2B3.2B2.1B4.5B1.2B
Liabilities
Current Liabilities789.0M268.6M148.7M222.5M131.3M
Non-Current Liabilities2.2B677.7M482.5M1.2B275.8M
Total Liabilities3.0B946.3M631.2M1.4B407.1M
Equity
Total Shareholders Equity7.2B2.3B1.4B3.1B795.4M

Balance Sheet Composition

Arcadium Lithium plc Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income131.7M330.1M273.5M600.0K-16.3M
Operating Cash Flow-197.3M326.4M484.3M20.4M-4.3M
Investing Activities
Capital Expenditures-----
Investing Cash Flow597.7M98.8M-27.8M-11.4M-7.1M
Financing Activities
Dividends Paid----0
Financing Cash Flow492.4M-22.0M-15.7M180.8M-800.0K
Free Cash Flow-1.2B-29.8M117.8M-105.5M-117.7M

Cash Flow Trend

Arcadium Lithium plc Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 64.89
Forward P/E 34.35
Price to Book 1.00
Price to Sales 6.24
PEG Ratio 34.35

Profitability Ratios

Profit Margin 10.24%
Operating Margin 1.66%
Return on Equity 2.78%
Return on Assets 1.41%

Financial Health

Current Ratio 1.09
Debt to Equity 14.03
Beta 1.49

Per Share Data

EPS (TTM) $0.09
Book Value per Share $5.82
Revenue per Share $0.94

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
altm6.3B64.891.002.78%10.24%14.03
Linde plc 216.0B33.335.6917.01%20.02%60.56
Sherwin-Williams 86.6B32.6420.8870.22%11.63%329.97
Eastman Chemical 8.7B9.561.4716.03%9.85%86.00
Axalta Coating 6.4B14.183.0623.15%8.56%161.07
Albemarle 6.7B33.520.86-9.99%-22.39%35.76

Financial data is updated regularly. All figures are in the company's reporting currency.